BamSEC and AlphaSense Join Forces
Learn More

Spyre Therapeutics Inc.

NASDAQ: SYRE    
Share price (10/4/24): $29.15    
Market cap (10/4/24): $1.481 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 8-K 6 pages Spyre Therapeutics, Inc. Second Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Spyre Therapeutics, Inc. “Article VII: Director and Officer Liability
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Amendment to the Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock of Spyre Therapeutics, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware [Signature Page Follows]
12/34/56
EX-3.2
from S-1/A 21 pages Amended and Restated Bylaws of Spyre Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 21 pages Amended and Restated Bylaws of Spyre Therapeutics, Inc
12/34/56
EX-3.4
from S-1 12 pages Spyre Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from S-1 13 pages Aeglea Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.2
from S-1 19 pages Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws as Amended and Restated on December 15, 2022 1 Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws as Amended and Restated on December 15, 2022
12/34/56
EX-3.1
from S-1 6 pages Aeglea Biotherapeutics, Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 12 pages Spyre Therapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series B Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 6 pages Aeglea Biotherapeutics, Inc. Amended and Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 1 page Second Certificate of Amendment of the Restated Certificate of Incorporation of Aeglea Biotherapeutics, Inc
12/34/56
EX-3.4
from S-1/A 13 pages Aeglea Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.3
from S-1/A 19 pages Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws as Amended and Restated on December 15, 2022 1 Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws as Amended and Restated on December 15, 2022
12/34/56
EX-3.2
from S-1/A 3 pages Certificate of Amendment to the Restated Certificate of Incorporation of Aeglea Biotherapeutics, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from S-1/A 5 pages Aeglea Biotherapeutics, Inc. Restated Certificate of Incorporation
12/34/56
EX-3.1
from 8-K 3 pages Certificate of Amendment to the Restated Certificate of Incorporation of Aeglea Biotherapeutics, Inc. Pursuant to Section 242 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 13 pages Aeglea Biotherapeutics, Inc. Certificate of Designation of Preferences, Rights and Limitations of Series a Non-Voting Convertible Preferred Stock Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.1
from 8-K 21 pages Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws as Amended and Restated on December 15, 2022 1 Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws
12/34/56
EX-3.1
from 8-K 14 pages Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws as Amended and Restated on March 31, 2020 Aeglea Biotherapeutics, Inc., a Delaware Corporation Amended and Restated Bylaws
12/34/56